Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-b (Q37235875)
Jump to navigation
Jump to search
scientific article published on 14 April 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-b |
scientific article published on 14 April 2009 |
Statements
1 reference
Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-b (English)
1 reference
Michael A Nauck
1 reference
Robert E Ratner
1 reference
Christoph Kapitza
1 reference
Rachele Berria
1 reference
Mark Boldrin
1 reference
Raffaella Balena
1 reference
Identifiers
1 reference